agilon health annual return on equity
2021
2022
2023
2024
2025
agilon health Return on Equity (ROE) Growth & History (AGL)
agilon health's return on equity was −130.95% for fiscal 2025.
View full agilon health company overviewagilon health annual return on equity history
| Fiscal year | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −130.95% | −85.02 pp |
| 2024 | 2024-12-31 | −45.93% | −15.09 pp |
| 2023 | 2023-12-31 | −30.84% | −20.85 pp |
| 2022 | 2022-12-31 | −9.99% | +90.73 pp |
| 2021 | 2021-12-31 | −100.72% | — |
agilon health quarterly return on equity
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | 8.78% | +31.74 pp |
| Q1 2026 | 2026-03-31 | 31.75% | +29.25 pp |
| Q4 2025 | 2025-12-31 | −87.28% | −67.05 pp |
| Q3 2025 | 2025-09-30 | −30.83% | −12.03 pp |
| Q2 2025 | 2025-06-30 | −22.96% | −18.47 pp |
| Q1 2025 | 2025-03-31 | 2.49% | +3.39 pp |
| Q4 2024 | 2024-12-31 | −20.23% | +9.81 pp |
| Q3 2024 | 2024-09-30 | −18.80% | −15.21 pp |
| Q2 2024 | 2024-06-30 | −4.49% | −2.79 pp |
| Q1 2024 | 2024-03-31 | −0.90% | −2.41 pp |
| Q4 2023 | 2023-12-31 | −30.04% | −24.73 pp |
| Q3 2023 | 2023-09-30 | −3.59% | −0.79 pp |
| Q2 2023 | 2023-06-30 | −1.71% | +0.16 pp |
| Q1 2023 | 2023-03-31 | 1.51% | +1.40 pp |
| Q4 2022 | 2022-12-31 | −5.31% | −0.20 pp |
| Q3 2022 | 2022-09-30 | −2.80% | +0.35 pp |
| Q2 2022 | 2022-06-30 | −1.86% | +68.26 pp |
| Q1 2022 | 2022-03-31 | 0.11% | — |
| Q4 2021 | 2021-12-31 | −5.11% | — |
| Q3 2021 | 2021-09-30 | −3.15% | — |
| Q2 2021 | 2021-06-30 | −70.13% | — |
agilon health return on equity trends
Between the periods ended 2021-12-31 and 2025-12-31, agilon health's return on equity decreased from −100.72% to −130.95%, a change of −30.23 percentage points. The latest reported quarter, Q2 2026, shows 8.78%.
About the metric
What return on equity (ROE) means
Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.
Calculation and source
How return on equity is calculated
TickerStat calculates ROE as SEC-reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review agilon health source filings ↗